Sernova Biotherapeutics Inc (TSX:SVA)
Canada · Delayed Price · Currency is CAD 0.1100
0.00 (0.00%)
Aug 14, 2026, 2:23 PM EST
Sernova Biotherapeutics Market Cap
Sernova Biotherapeutics has a market cap or net worth of CAD 41.54 million as of August 14, 2026. Its market cap has decreased by -36.77% in one year.
Market Cap
41.54M
Enterprise Value
54.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
ChartMarket Cap Chart
Since June 29, 2000, Sernova Biotherapeutics's market cap has increased from 17.04M to 41.54M, an increase of 143.83%. That is a compound annual growth rate of 3.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 41.54M | -5.10% |
| Dec 31, 2025 | 43.77M | -40.78% |
| Dec 31, 2024 | 73.91M | -67.09% |
| Dec 29, 2023 | 224.60M | -3.01% |
| Dec 30, 2022 | 231.57M | -51.28% |
| Dec 31, 2021 | 475.26M | 238.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sona Nanotech | 44.21M |
| NurExone Biologic | 44.20M |
| Medicenna Therapeutics | 42.46M |
| MedMira | 42.10M |
| BriaCell Therapeutics | 41.15M |
| Microbix Biosystems | 41.09M |
| Thiogenesis Therapeutics | 38.49M |
| Onco-Innovations | 37.57M |